Competitive inhibition of the high-affinity choline transporter by tetrahydropyrimidine anthelmintics

• Published in: European journal of pharmacology Vol. 898; p. 173986
• Main Authors: Okuda, Takashi, Nomura, Yuki, Konishi, Asami, Misawa, Hidemi
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 05.05.2021
• Subjects: Acetylcholine; Animals; Anthelmintics - metabolism; Anthelmintics - pharmacology; Binding, Competitive; Biological Transport; Brain - drug effects; Brain - metabolism; Cation Transport Proteins - antagonists & inhibitors; Cation Transport Proteins - metabolism; Choline - metabolism; CHT1; Competitive inhibitor; Female; HEK293 Cells; High-affinity choline transporter; Humans; Ligand screening; Ligands; Mice; Morantel - metabolism; Morantel - pharmacology; Protein Binding; Protein Transport; Pyrantel - analogs & derivatives; Pyrantel - metabolism; Pyrantel - pharmacology; Pyrimidines - metabolism; Pyrimidines - pharmacology; Symporters - antagonists & inhibitors; Symporters - genetics; Symporters - metabolism; Synaptosomes - drug effects; Synaptosomes - metabolism; Tetrahydropyrimidine anthelmintics; Ligand screening; Tetrahydropyrimidine anthelmintics; High-affinity choline transporter; Acetylcholine; CHT1; Competitive inhibitor
• ISSN: 0014-2999; 1879-0712
• DOI: 10.1016/j.ejphar.2021.173986

The high-affinity choline transporter CHT1 mediates choline uptake, the rate-limiting and regulatory step in acetylcholine synthesis at cholinergic presynaptic terminals. CHT1-medated choline uptake is specifically inhibited by hemicholinium-3, which is a type of choline analog that acts as a competitive inhibitor. Although the substrate choline and the inhibitor hemicholinium-3 are well-established ligands of CHT1, few potent ligands other than choline analogs have been reported. Here we show that tetrahydropyrimidine anthelmintics, known as nicotinic acetylcholine receptor agonists, act as competitive inhibitors of CHT1. A ligand-dependent trafficking assay in cell lines expressing human CHT1 was designed to search for CHT1 ligands from a collection of biologically active compounds. We found that morantel as well as other tetrahydropyrimidines, pyrantel and oxantel, potently inhibits the high-affinity choline uptake activity of CHT1 in a competitive manner similar to the inhibitor hemicholinium-3. They also inhibit the high-affinity choline transporter from the nematode Caenorhabditis elegans. Finally, tetrahydropyrimidines potently inhibit the high-affinity choline uptake in rat brain synaptosomes at a low micromolar level, resulting in the inhibition of acetylcholine synthesis. The rank order of potency in synaptosomes is as follows: morantel > pyarantel > oxantel (Ki = 1.3, 5.7, and 8.3 μM, respectively). Our results reveal that tetrahydropyrimidine anthelmintics are novel CHT1 ligands that inhibit the high-affinity choline uptake for acetylcholine synthesis in cholinergic neurons.